Intron Biotechnology, Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Seongnam Korea, Republic of (1999)
Status: No NME R&D (1999)

Organization Overview

First Clinical Trial
2013
NCT01855048
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Intron Biotechnology, Inc.